Sign in

Birkenstock Holding plc BIRK

Price 34.0 USD
as of 2026-09-05
57/100
Mixed
Quality66
Growth71
Balance-sheet strength68
Valuation51
Momentum24
Income50

Composite 57/100; the shares have moved about 61% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Momentum ranks 24/100 — a strong mark against it.

Case for

Growth ranks 71/100 — a moderate point in its favour. Balance-sheet strength ranks 68/100 — a moderate point in its favour. Quality ranks 66/100 — a moderate point in its favour.

Case against

Momentum ranks 24/100 — a strong mark against it.

What the company does Birkenstock Holding plc designs, manufactures, and sells premium footbed-based footwear and accessories globally. Its portfolio includes sandals, closed-toe shoes, skincare products, and accessories sold via e-commerce, owned retail stores, and wholesale partners.

Key financials Gross margin 57.8%, operating margin 26.9%, net margin 16.3%. ROE 12.5%, ROA 6.7%, ROCE 11.6%. Revenue grew 7.7% while EPS fell -20.4%. Debt/equity 0.48, net debt/EBITDA 1.90, interest coverage 7.90.

Stock health Sideravia overall score 53.9 (average quality, fairly valued). Strength 73.1, Valuation 54.6, but Growth 34.9 and Momentum 39.2 lag. Piotroski F-Score 7/9, Altman Z 3.20, RSI(14) 37.40.

Price vs fair value The stock trades at a PREMIUM of 27.10% versus our fair-value estimate and a discount of 31.99% versus the analyst 12-month target. - Foot Locker expansion in Boulder and West Palm Beach supports growth narrative (Footwear News) - Options activity signals potential volatility ahead (Zacks) - Margin strength highlighted by sell-side commentary (Insider Monkey)

Looking forward Forward P/E 14.71 and PEG 0.56 suggest undemanding valuation relative to growth, but recent EPS decline (-20.4%) and weak momentum (-23.97% over 12m) temper enthusiasm. Analysts target 52.28 implies 32% upside from current price.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.